This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Global Biotechnology, Ibisworld

NEW YORK, Nov. 20, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Global Biotechnology, Ibisworld

http://www.reportlinker.com/p01045182/Global-Biotechnology-Ibisworld.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biotechnology

Global Biotechnology

In the past five years, the global recession tempered demand for nonessential health products and reduced funding for biotechnology research and development from private investors. Despite these factors, industry firms thrived on the back of technological advances that facilitated new discoveries and stimulated greater demand from firms in the pharmaceuticals and agricultural sectors. Industry growth is forecast to continue skyrocketing in the next five-year period as investment in biotechnology from around the world increases, particularly from emerging economies.

Firms in this industry primarily engage in the application of living organisms or molecular and cellular techniques to develop products that are used in agriculture, food, industrial and medicine production.

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.

TABLE OF CONTENTS

ABOUT THIS INDUSTRY

Industry Definition

Main Activities

Similar Industries

Additional Resources

INDUSTRY PERFORMANCEExecutive SummaryKey External DriversCurrent PerformanceIndustry OutlookIndustry Life Cycle

PRODUCTS & MARKETS

Supply Chain

Products & Services

Demand Determinants

Major Markets

International Trade

Business Locations

COMPETITIVE LANDSCAPEMarket Share ConcentrationKey Success FactorsCost Structure BenchmarksBasis of CompetitionBarriers to EntryIndustry Globalization

MAJOR COMPANIES

OPERATING CONDITIONSCapital IntensityTechnology & SystemsRevenue VolatilityRegulation & PolicyIndustry Assistance

KEY STATISTICS

Industry Data

Annual Change

Key Ratios

JARGON

MAJOR COMPANIES

Amgen Inc.

Merck KGaA

Roche Holding AG To order this report: Biotechnology Industry: Global Biotechnology, Ibisworld Nicolas BombourgReportlinkerEmail: nicolasbombourg@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626

SOURCE Reportlinker

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,515.14 +163.76 1.00%
S&P 500 1,973.75 +24.89 1.28%
NASDAQ 4,796.08 +46.1010 0.97%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs